Fig. 1From: Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancerKaplan-Meier survival curves of progression-free survival and overall survival in the BBP group (n = 37) and in the non-BBP group (n = 25)Back to article page